Brain biopsy Doctors Abroad — Page 3

Dr. Yusuf Acikgoz is a medical oncologist at Lokman Hekim University Ankara Hospital. He specializes in treating complex cancers, including lung, breast, and liver malignancies. He completed a fellowship at Ohio State University in the United States. Dr. Acikgoz manages treatments like chemotherapy, radioembolization, and immunotherapy.

• Member of the American Society of Clinical Oncology (ASCO).
• Assistant Investigator for Phase III clinical trials, including the CheckMate-649 study.
• Certified in Good Clinical Practice and Human Subjects Protection at Ohio State University.
• Performs diagnostic procedures like biopsy, gastroscopy, and tumor marker testing.

Dr. Tural Rajabov is a neurosurgeon. He treats brain and spinal cord tumors, CNS trauma, and hydrocephalus. He also performs endoscopic skull base surgery, spinal surgery, and peripheral nerve surgery.

Training: Tbilisi State Medical University, Faculty of Medicine (2010–2016). Internship in Neurosurgery, Innova Medical Centre, Tbilisi (2016–2018). Residency in Neurosurgery, Azerbaijan Medical University (2019–2024).

Professional memberships: North American Skull Base Society (NASBS), European Association of Neurosurgical Societies (EANS), and Azerbaijan Association of Neurosurgeons (ANEA). He is affiliated with Baku Medical Plaza Hospital in Baku, Azerbaijan.

Dr. Marcel Dihne is the Chief Physician of Neurology at the Academic Hospital Solingen. He is a recipient of the Research Award from the Christian and Claudia Hempel Foundation. Dr. Dihne specializes in epilepsy, stroke treatment, and the regeneration of the nervous system. He has authored numerous publications in leading European medical journals.

• Served as the Head of Neurology at St. Lukas Klinik Solingen for 10 years.
• Treats complex conditions like Parkinson’s disease, multiple sclerosis, and chronic pain.
• Performs specialized procedures including vagus nerve stimulation and video-EEG monitoring.
• Works at an academic hospital ranked among the top clinics in Germany by Focus magazine.

Dr. Viola Fox is the Chief Physician at the Clinic for Oncology in Solingen. She is a leading expert in drug therapy for tumors in Germany and Europe. Dr. Fox holds a qualification in specialist genetics and conducts molecular biology research. She treats complex cases at a certified interdisciplinary cancer center.

• Member of the American Association for Cancer Research.
• Specializes in immunotherapy, targeted therapy, and molecular diagnostics.
• Treats hematological diseases, including lymphoma, leukemia, and myeloma.
• Works at Städtisches Klinikum Solingen, a clinic ranked among the top in Germany.

Dr. Ibrahim Bayar Cinar is a cardiovascular surgeon at Medical Park Bahcelievler Hospital in Istanbul. He specializes in treating mitral valve prolapse and aortic valve insufficiency. Dr. Cinar completed a clinical fellowship at the University of Ottawa Heart Center in Canada. He holds memberships in the European Society for Cardiovascular Surgery and Vascular Surgery.

• Served as a Professor of Cardiovascular Surgery at Altınbaş University.
• Treats complex conditions like aorto-mesenteric artery compression syndrome.
• Performs cardiac procedures at a JCI-accredited university hospital.
• Practices at a national reference center for cardiovascular surgery and intensive care.

Dr. Mehmet Hakan Şahin is a neurosurgeon at Atlas University Hospital (as of 2026). He specializes in neuro-oncological and neurovascular surgery. He also performs skull base, complex cranial, and spine surgery. He was an Assistant Professor at Atatürk University (2019–2024). He served at UW Health (2024–2025).

He has 29 international peer-reviewed papers and 11 national papers. He has written 5 textbook chapters. He has given 7 oral presentations, including at AANS 2025 and a 2024 panel on supratotal glioma resection. His honors include the 2024 Turkish Neurosurgery Association Young Neurosurgeon Incentive Award (Second Prize) and 1st Prize at the 1st Yaşargil Microneurosurgery Academy. He holds the Turkish Neurosurgery Qualification Certificate (2023). He has been a member of the Turkish Neurosurgery Association since 2017 (No. 1620).

Dr. Ali Osman Mucuoglu is a neurosurgeon at Atlas University Hospital in Istanbul. He specializes in brain tumor removal and minimally invasive intracerebral hemorrhage surgery. Dr. Mucuoglu utilized 3D printing technology for assisted transsphenoidal hypophysectomy. He is a member of the European Association of Neurosurgical Societies.

• Completed neurosurgery training at Dokuz Eylül University.
• Treats complex conditions including spinal stenosis, spondylolisthesis, and acoustic neuroma.
• Performs deep brain stimulation (DBS) and vagus nerve stimulation surgery.
• Specialized in surgical neuroanatomy and head injury management.

Dr. Irfan Cicin is a Professor of Medical Oncology at İstinye University Liv Hospital Topkapı. He specializes in treating complex cancers, including glioblastoma, lung cancer, and pancreatic tumors. He serves as a professor at the Trakya University Faculty of Medicine. Dr. Cicin previously served as a physician in the Turkish Air Force.

• Performs systemic therapies such as immunotherapy, chemotherapy, and hormone therapy.
• Treats a wide range of conditions including gynecologic, orthopedic, and neuro-oncology cases.
• Expert in HIPEC and chemoembolization for liver and abdominal malignancies.
• Works at a 300-bed university hospital with 33 medical departments.

Dr. Fatma Gulhan Sahbaz is a neurologist at Medicalpoint International Hospital in İzmir. She is a former Clinic Chief at Afyonkarahisar State Hospital. Dr. Sahbaz focuses on movement disorders, stroke intervention, and epilepsy. She treats complex neurodegenerative diseases like Alzheimer’s and ALS.

• Member of the International Parkinson and Movement Disorder Society.
• Treats patients using deep brain stimulation and apomorphine pumps.
• Performs greater occipital nerve blocks for chronic headache management.
• Practices at JCI-accredited Medicalpoint International Hospital.

Dr. Jesus Romero Imbroda is a neurologist at Quirónsalud Marbella. He is a Fellow of the European Board of Neurology. Dr. Romero Imbroda serves as an academic at the Royal Academy of Medicine. He focuses on multiple sclerosis research and complex neuromuscular disorders. The doctor also teaches at the University of Granada.

• Former President of the Andalusian Society of Neurology.
• Served on the Internal Residential Doctor Assessment Committee.
• Treats Parkinson's disease, epilepsy, and cognitive conditions.
• Performs deep brain stimulation and spinal cord stimulator procedures.

Dr. Halil Can is a Professor of Neurosurgery at İstinye University Liv Hospital Topkapı. He specializes in endoscopic and microsurgical spine surgery for tumors and degenerative diseases. Dr. Can is an author of 21 international peer-reviewed publications. He performs complex procedures including endoscopic skull base and pituitary surgery.

• Conducted Phase I safety trials for stem-cell treatments in spinal cord injuries.
• Reported on surgical outcomes for 81 posterior circulation aneurysm cases.
• Expert in advanced pain management like intradiscal ozone therapy and laser nucleoplasty.
• Performs functional neurosurgery including Parkinson's surgery and spinal cord stimulator implantation.

Dr. Evren Sandal is a neurosurgeon at Medicalpoint International Hospital in İzmir. He specializes in skull base, neurovascular, and craniocervical junction surgery. Dr. Sandal completed focused research in cerebral bypass surgery at the University of Wisconsin, USA. He treats complex conditions including brain tumors, spinal stenosis, and brain cysts.

• Trained in skull base surgery at a leading US university medical center.
• Performs specialized procedures like discectomy and deep brain stimulation (DBS).
• Collaborated with global experts in craniocervical junction and cerebral bypass techniques.
• Works at JCI-accredited Medicalpoint Hospital, which features a dedicated Robotic Surgery Center.

Dr. Muhammed Mustafa Atci is an Associate Professor of Medical Oncology at Liv Hospital Topkapı. He specializes in treating colon, breast, gastric, and lung cancers. He previously served as the Education Coordinator at Prof. Dr. Cemil Taşcıoğlu City Hospital. Dr. Atci is a member of the American Society of Clinical Oncology (ASCO).

• Author of 19 peer-reviewed papers on gastrointestinal, thoracic, and endocrine cancers.
• Published studies on survival outcomes for stage IIB colon cancer in the Journal of Chemotherapy.
• Researches prognostic biomarkers using PET/CT scans and metabolic tumor volume.
• Treats complex oncological cases at the university-affiliated İstinye University clinic.

The doctor is a distinguished neurologist and the principal investigator of 100 clinical trials, with a specialized focus on multiple sclerosis, Parkinson's disease, Alzheimer's, and amyotrophic lateral sclerosis. The specialist utilizes advanced therapeutic interventions, including plasmapheresis and neurorehabilitation technologies like the Exoskeleton.

With a career spanning leadership roles as Head of Neurology at major university hospitals, the doctor holds an accreditation as a Professor of Medical Sciences. An accomplished researcher, the specialist has authored over 400 scientific works, including 139 international articles cited more than 4,500 times, and has led numerous research projects funded by the Carlos III Institute of Health.

Dr. Yaacov Lawrence is the Chair of Radiation Oncology at Sheba Medical Center. He specializes in precision radiation therapy and neuro-oncology. Dr. Lawrence pioneered celiac plexus radiosurgery for pancreatic cancer pain management. He holds the FASTRO designation, one of the highest honors in his specialty.

• Leads the Gastrointestinal Cancer Program at Sheba Medical Center.
• Performs stereotactic radiosurgery for brain tumors and nervous system cancers.
• Authored over 280 scientific publications on personalized radiation protocols.
• Completed radiation oncology fellowship training at Thomas Jefferson University.

Dr. Anton Wohl is the Director of the Brain Tumors Unit at Sheba Medical Center. He specializes in neuro-oncology and complex brain tumor surgery. He completed fellowships at the Mayo Clinic in the USA. Dr. Wohl works at a hospital ranked 7th globally by Newsweek in 2026. He focuses on removing tumors while preserving neurological function.

• Performs awake craniotomy and fluorescence-guided surgery to protect brain function.
• Uses intraoperative MRI and functional brain mapping during complex procedures.
• Author of multiple peer-reviewed studies on glioblastoma and innovative therapies.
• Holds Israeli board certification and an active medical license.

Dr. Alper Karaoglan is a Professor of Neurosurgery at Memorial Bodrum Hospital. He specializes in treating brain tumors, aneurysms, and spinal conditions like spondylolisthesis. He has held senior academic roles at Maltepe University for over 15 years. Dr. Karaoglan won the Best Paper Award from the Turkish Neurosurgical Society.

• Specializes in pituitary adenomas, cavernomas, and arteriovenous malformations.
• Received the Young Neurosurgeon Encouragement Award from the Turkish Neurosurgical Society.
• Member of the Turkish Medical Association and the Turkish Neurosurgical Society.
• Treats complex conditions including Moyamoya disease and craniostenosis.

Zhang Jinshan, male, China’s First M.D. in the Radiation Medicine, CCI (Chinese College of Interventionalists) Master Interventionalist, Director of the Department of Former Radiological Diagnosis at Chinese PLA General Hospital(No.3 in China) Ph.D. of Medicine, Nagasaki University, Japan.

1980–1985: Completed doctoral studies at Nagasaki University, Japan

1968–present: Department of Radiology, Chinese PLA General Hospital

1988: Third Prize of the Military Science and Technology Progress Award

1989–present: Member of Radiological Society of North America(RSNA)

1990–2009: Standing Committee Member of the Radiology and Therapeutic Radiology Committee of the PLA

1991: Second Prize of the Military Science and Technology Progress Award

1992–2008: Group Leader of the Group of Intervention of Chinese Journal of Radiology

1992–2015: Standing Editorial Board Member and Editorial Board Member of Journal of Interventional Radiology

1993: Granted the Lifetime Special Government Allowance of the State Council

1993–2012: Deputy Chief Editor of Chinese Journal of Medical Image Technology

1994: Third Prize of the Military Science and Technology Progress Award

1997: Second Prize of the Military Science and Technology Progress Award

1997–2009: Standing Member of Chinese Society of Radiology

1999: Third Prize of the Military Science and Technology Progress Award

1999–2010: Deputy Director Member of Chinese Society of Interventional Oncology

2002: Second Prize of the Military Science and Technology Progress Award

2005: Third Prize of the Military Science and Technology Progress Award

Member of Radiological Society of North America(RSNA)

Standing Member of Chinese Society of Radiology

Group Leader of the Group of Intervention of Chinese Journal of Radiology

Deputy Director Member of Chinese Society of Interventional Oncology

Director Member of Beijing Medical Association Society of Interventional Radiology

Deputy Chief Editor of Chinese Journal of Medical Image Technology

Standing Member of Professional Committee of Radiological Medicine of the Chinese People’s Liberation Army

Standing Editorial Board Member and Editorial Board Member of Journal of Interventional Radiology

Awarded the Special Government Allowance of the State Council

Awarded three Second Prizes and four Third Prizes for Military Science and Technology Progress.

Awarded the honorary title of “Chinese College of Interventionalists(CCI) Master Interventionalist”

Led multiple national and provincial/ministerial scientific research projects, including two projects funded by the National Natural Science Foundation of China and two projects funded by the Department of Science and Technology of Sichuan Province.

In the pioneering development of interventional medicine in China, Zhang Jinshan has been an indispensable founder and leading figure. As China’s first overseas-trained doctoral graduate in radiological medicine, he returned to China in the 1980s after completing his studies abroad and introduced cutting-edge international interventional technologies to the country. Over more than four decades of dedicated practice and research, he has helped propel Chinese interventional medicine from its infancy to a position at the forefront of the global field through his exceptional clinical expertise and profound academic accomplishments.

Professor Zhang Jinshan has long been dedicated to the field of medical imaging and has developed distinctive expertise in selective and superselective interventional diagnosis and treatment for solid tumors such as liver cancer, demonstrating exceptional technical proficiency and profound academic accomplishment. Beginning in the 1990s, he led his team in pioneering the clinical application and research of TIPSS and B-ORTO in China, filling major gaps in the domestic field and opening new paths for the interventional management of gastrointestinal bleeding caused by portal hypertension secondary to liver cirrhosis. In addition, he has made groundbreaking contributions to the interventional diagnosis and treatment of peripheral vascular diseases, as well as to preoperative embolization for spinal tumors.

In the field of liver cancer treatment, Professor Zhang Jinshan not only led the development of standardized treatment protocols for liver cancer but also pioneered Transcatheter Arterial Chemoembolization with temporary Hepatic Vein Thrombosis (TACE-THVO) for primary liver cancer, bringing the efficacy of interventional therapy to a new level. In recognition of his outstanding clinical and scientific contributions, he was awarded the honorary title of “Chinese Master of Interventional Radiology” at the 2019 annual conference of the Chinese College of Interventionalists.

Professor Zhang Jinshan is not only a master clinician but also a driving force in the development of the discipline and a dedicated mentor in talent cultivation. He led his team in establishing one of China’s premier interventional therapy centers. As a doctoral supervisor, he has trained a large number of outstanding specialists and future leaders in interventional medicine, with many of his students and protégés now serving across the country. Academically, he has led multiple key national and military research projects, published more than 300 academic papers, and served as chief editor of three monographs, making remarkable contributions to the establishment of China’s academic framework for interventional medicine and the nationwide dissemination of its technologies.

From the laboratory to the operating room, and from academic podiums to grassroots hospitals, Professor Zhang Jinshan has consistently upheld the principles of “pioneering, innovation, pragmatism, and compassion". He has devoted his life to fulfilling the mission of a physician—relieving patients’ suffering through minimally invasive techniques and advancing the discipline through academic excellence—thereby establishing himself as a truly towering figure and one of the foremost authorities in the field of interventional medicine in China.

Professor Zhang Jinshan’s Academic Achievements

Professor Zhang Jinshan has achieved prolific academic accomplishments, having published over 300 academic papers covering areas such as interventional therapy for liver cancer, minimally invasive treatment of portal hypertension, interventional treatment of vascular diseases, and tumor ablation.

Selected Publications by Professor Zhang Jinshan

1. Zhang Jinshan, Wang Maoqiang. Experiments and Clinical Studies of transjugular intrahepatic portosystemic stent shunt (TIPSS). Chinese Journal of Radiology, 1993，27（6）：361-365.

Professor Zhang Jinshan is the first author. This is one of the early research papers in China that systematically elaborates on the TIPSS technique. Through animal experiments and clinical case analysis, it confirmed that TIPSS is a safe and effective minimally invasive method for treating portal hypertension and its complications, laying an important foundation for the promotion and application of this technique in China.

2.Zhang Jinshan, Li Huai. Clinical study on transcatheter arterial embolization with temporary hepatic vein occlusion for the treatment of primary liver cancer.Chinese Journal of Radiology, 1996，30（8）：521-524.

Professor Zhang Jinshan is the first author. He innovatively proposed the technique of "transcatheter arterial embolization with temporary hepatic vein occlusion." Clinical results demonstrated that this method can significantly increase the drug concentration within liver cancer lesions, reduce damage to normal liver tissue, and effectively improve the therapeutic outcomes for intermediate and advanced liver cancer, providing a novel strategy for the interventional treatment of liver cancer.

3. Zhang Jinshan, Wang Maoqiang, Li Huai. Interventional treatment of Budd-Chiari syndrome. Chinese Journal of Medical Imaging Technology, 1998，14（3）：189-191.

Professor Zhang Jinshan is the first author. This paper systematically summarizes the early experience in interventional treatment of Budd-Chiari syndrome in China, elaborating in detail on the key operational points and therapeutic efficacy of techniques such as percutaneous transluminal angioplasty and stent placement. It confirms that interventional therapy is the preferred minimally invasive method for Budd-Chiari syndrome, promoting the standardized development of treatment for this disease.

4.Zhang Jinshan, Li Huai, Wang Maoqiang. Clinical value of superselective hepatic arterial chemoembolization in the treatment of hypovascular liver cancer. Chinese Journal of Radiology, 2000，34（5）：335-337.

Professor Zhang Jinshan is the first author. Addressing the challenges in interventional treatment of hypovascular liver cancer, this paper explores the clinical efficacy of superselective hepatic arterial chemoembolization. The results indicate that this technique can precisely target the lesions and improve the treatment response rate, providing an important clinical basis for the interventional treatment of hypovascular liver cancer.

5. Zhang Jinshan, Li Huai, Wang Maoqiang. Interventional treatment of peripheral vascular stenosis and occlusion.Chinese Journal of Radiology, 2002，36（7）：612-614.

Professor Zhang Jinshan is the first author. This paper summarizes the interventional treatment experience of over 400 patients with peripheral vascular stenosis and occlusion, analyzing the indications and efficacy of techniques such as balloon angioplasty and stent placement. It confirms that interventional therapy is a safe and effective approach for peripheral vascular diseases, providing practical support for its clinical promotion.

6.Zhang Jinshan, Li Huai, Wang Maoqiang. Clinical application of CT-guided percutaneous puncture ablation in the treatment of abdominal tumors. Chinese Journal of Medical Imaging Technology, 2004，20（9）：1395-1397.

Professor Zhang Jinshan is the first author. This paper explores the application value of CT-guided percutaneous puncture techniques such as radiofrequency ablation and chemical ablation in the treatment of abdominal tumors. The clinical results show that this method is minimally invasive with reliable efficacy, offering a minimally invasive treatment option for patients with inoperable abdominal tumors.

7.Zhang Jinshan, Wang Maoqiang, Li Huai. Advances in the application of interventional therapy for benign prostatic hyperplasia. Chinese Journal of Radiology, 2006，40（8）：876-878.

Professor Zhang Jinshan is the corresponding author. This paper systematically reviews the cutting-edge advances in interventional therapy for benign prostatic hyperplasia, including the principles, procedures, and efficacy of techniques such as prostatic artery embolization and stent placement, providing new insights for the minimally invasive treatment of benign prostatic hyperplasia.

8.Zhang Jinshan, Li Huai, Wang Maoqiang. Discussion on the standardization of interventional therapy for liver cancer. Chinese Journal of Practical Surgery, 2008，28（10）：856-858.

Professor Zhang Jinshan is the corresponding author. Drawing on years of clinical experience and research findings, he led the discussion on standardized protocols for interventional therapy of liver cancer, covering key aspects such as preoperative assessment, treatment modality selection, and postoperative management, providing important references for the formulation of clinical guidelines for interventional therapy of liver cancer in China.

Professor Zhang Jinshan co-authored monographs

1. Interventional Radiology (People's Military Medical Press, 1995): The first monograph in China to systematically discuss the theories and techniques of interventional radiology. It comprehensively elaborates on the interventional diagnosis and treatment system for tumors, vascular diseases, and non-vascular diseases, becoming a classic essential textbook for interventional physicians in China.

2.Interventional Therapy for Liver Cancer (People's Health Press, 2001): Focusing on minimally invasive interventions for liver cancer, this book systematically summarizes techniques such as TACE, ablation, and vascular intervention, refines operational standards and the prevention and management of complications, and promotes the standardization of interventional therapy for liver cancer.

3.Interventional Treatment of Portal Hypertension (Science Press, 2005): This book systematically elaborates on minimally invasive techniques for portal hypertension, such as TIPSS and B-ORTO, covering experimental research, clinical procedures, long-term follow-up, and efficacy evaluation, filling the gap in monographs on interventional treatment of portal hypertension in China.

Professor Zhang Jinshan’s Research project

1.The National "Eighth Five-Year Plan" Scientific and Technological Key Project—Clinical and Basic Research on Comprehensive Interventional Therapy for Liver Cancer (Project Leader): This project systematically explored multimodal interventional strategies for liver cancer, established the core regimen of superselective TACE combined with local ablation, and significantly improved the therapeutic outcomes for intermediate and advanced liver cancer.

2.The Military "Ninth Five-Year Plan" Key Medical Scientific Research Project—Standardized Research on TIPSS for the Treatment of Portal Hypertension (Project Leader): This project formulated China's first operational standards and postoperative management guidelines for TIPSS, reduced the incidence of complications, and promoted the popularization of this technique throughout the military and across the country.

3.National Natural Science Foundation of China Project — Research on the Mechanism of Targeted Therapy for Liver Cancer Using Hepatic Vein Occlusion Combined with Chemoembolization (Project Leader): This project revealed the synergistic enhancement mechanisms of the innovative technique at the levels of hemodynamics, drug metabolism, and the tumor microenvironment, providing theoretical support for precision interventional therapy of liver cancer.

4.Military Clinical High-Tech Major Project-Establishment and Clinical Application of the Interventional Treatment Technology System for Complex Vascular Diseases (Project Leader): This project overcame interventional challenges in complex lesions such as Budd-Chiari syndrome, peripheral vascular occlusion, and vascular malformations, forming a complete technical system that has been promoted and applied widely.

Dr. Yang Se Yeon is a neurosurgeon and Head of the Department of Neurosurgery at Naeun Hospital. He specializes in cerebral infarction, cerebral hemorrhage, cerebral aneurysm, moyamoya disease, carotid artery stenosis, vascular dizziness, and head trauma.

He graduated from The Catholic University of Korea College of Medicine. He also earned a Master’s in Medicine there. He completed an internship and a neurosurgery residency at Catholic Medical Center. He then completed a clinical fellowship and served as a clinical assistant professor at Uijeongbu St. Mary’s Hospital.

He has served as a staff neurosurgeon at the Northern Gyeonggi Regional Trauma Center. He was also Head of Neurosurgery at G-SAM Hospital.

Dr. Wutthiphong Wilaiwarangkun is a neurologist licensed by the Medical Council of Thailand (licence ว.49590). He works at the Neuro Med Clinic, Pacific Garden Hospital in Sriracha, Chonburi. He provides consultation, diagnosis, and long-term care for neurological disorders.

He earned his M.D. from Walailak University. He holds the Diploma of the Thai Board of Neurology from Rajavithi Hospital, part of the Department of Medical Services, Ministry of Public Health. Rajavithi Hospital is an accredited tertiary referral centre. It manages a high volume of cases in cerebrovascular disease, epilepsy, neurodegenerative disorders, and neuromuscular conditions from across Thailand.

He previously served as a neurology specialist at Satun Hospital. His work covered acute stroke, emergency neurology, and inpatient and outpatient care. He brings broad provincial experience to his current practice.